Tag Archives: PARKINSONS

Medical Mondays | Cannabis Therapeutics and the Future of Neurology

By Ethan B. Russo | 18th Octobre 2018 Neurological therapeutics have been hampered by its inability to advance beyond symptomatic treatment of neurodegenerative disorders into the realm of actual palliation, arrest or reversal of the attendant pathological processes. While cannabis-based medicines have demonstrated safety, efficacy and consistency sufficient for regulatory approval in spasticity in multiple sclerosis (MS), and in Dravet and Lennox-Gastaut

Read more

Detailed analysis of selected pathological conditions and effects of cannabis and its derivatives with weaker clinical evidence and a strong theoretical basis favoring effectiveness. With reference to Parkinson’s disease.

A short quote from the .pdf (a link to the detailed analysis is at the end of this post). ” Parkinson’s disease This disease, whose symptoms especially include a decrease in the number of dopaminergic neurons in the basal ganglia (“BG”), is, due to its high prevalence (especially among older patients) and simultaneous existence of endocannabinoid receptors in the BG

Read more